stem cell transplant
Omisirge Approved for Patients With Blood Cancers to Reduce Infection Risk After Stem Cell Transplant
The FDA approved omidubicel-onlv (Omisirge, Gamida Cell), a substantially modified allogeneic (donor) cord ...
APRIL 19, 2023
Mainstay IBD Treatment Reduces Lower-GI aGvHD After Allo-HSCT
Vedolizumab (Entyvio, Millennium Pharmaceuticals), a drug used frequently for inflammatory bowel disease, improves ...
APRIL 10, 2023
Speedier Busulfan Washout A Plus in HCT Conditioning?
The washout period between the last dose of metronidazole and the first dose of the alkylating agent busulfan can ...
JULY 13, 2021
FDA Approves Prevymis for CMV Prevention in Allo-HCT Patients
The FDA approved Merck's Prevymis, Merck for prophylaxis of cytomegalovirus infection and disease in adult ...
NOVEMBER 13, 2017
Load more